Lv11
98 积分 2025-01-03 加入
ALK Translocation in ALK-Positive Mesenchymal Tumors: Diagnostic and Therapeutic Insights
3小时前
已完结
[ALK gene fusion associated non-small cell lung cancer: automated immunostainer detection and clinicopathologic perspectives]
3小时前
已关闭
ALK Translocation in ALK-Positive Mesenchymal Tumors: Diagnostic and Therapeutic Insights
4小时前
已完结
Differential Protein Stability and ALK Inhibitor Sensitivity of EML4-ALK Fusion Variants
4小时前
已完结
Iruplinalkib (WX-0593) Versus Crizotinib in ALK TKI-Naive Locally Advanced or Metastatic ALK-Positive NSCLC: Interim Analysis of a Randomized, Open-Label, Phase 3 Study (INSPIRE)
20天前
已完结
First-Line Crizotinib versus Chemotherapy in ALK-Positive Lung Cancer
20天前
已完结
Brief Report: Durvalumab After Chemoradiotherapy in Unresectable Stage III EGFR-Mutant NSCLC: A Post Hoc Subgroup Analysis From PACIFIC
1个月前
已完结
Alectinib in Resected ALK -Positive Non–Small-Cell Lung Cancer
1个月前
已完结
Erlotinib Versus Gemcitabine Plus Cisplatin as Neoadjuvant Treatment of Stage IIIA-N2 EGFR-Mutant Non–Small-Cell Lung Cancer (EMERGING-CTONG 1103): A Randomized Phase II Study
1个月前
已完结
Enfermedad neumocócica invasiva en la población menor de 5 años de edad de Navarra (2000-2005): impacto de la vacuna conjugada
1个月前
已完结
皖公网安备34019202002308
